Funded Projects
Home
About
Funded Projects
Partners
Governance
News
Contact
IPMP Funded Projects
All
2019
2020
2021
2022
NEW
Personalized treatment against Fusobacterium nucleatum in breast cancer patients
NEW
Closing the loop in brain disorders: Towards personalized human deep brain stimulation
NEW
Post mRNA vaccine myocarditis: epidemiology, long term clinical follow-up, genetic predisposition, and immune mechanism
NEW
The Challenge of pediatric acute myeloid leukemia - a precise personalized approach
NEW
Monitoring response to cancer treatment using point-of-care multimodal cfDNA profiling
NEW
Israeli preemies biobank: Identification and mechanistic characterization of barrier-modulating gut microbiota in premature infants
NEW
Deciphering the effects of anti-TNF Therapy on B cell responses in IDB patients
NEW
Identification of early systemic drivers of Alzheimer's disease in pre-clinical populations to develop personalized therapeutic approaches
NEW
What makes a stone? Unravling the molecular mechanism driving kidney stone formation
Third Cycle
PRIMALS - A Precision Medicine Biomarkers Study in ALS, Based on Pathology-Relevant Signals
Third Cycle
Improving Sonographic Diagnosis and Monitoring of Breast Cancer and Crohn’s Disease Using Artificial Intelligence and Super-Resolution Algorithms
Third Cycle
Personalized Optimization of Medical Therapy for Atrial Fibrillation Patients
Third Cycle
Characterization and Targeting of Cellular Senescence in Breast Tumors and their Microenvironment
Third Cycle
Unraveling Anatomically-Distinct Tumor-Immune Interactions in Melanoma Metastases by Multiplexed Imaging
Third Cycle
Solving the Unsolved: Integrated Computational and Functional Framework for Optimized Gene Identification and Therapy in Rare Hereditary Diseases
Third Cycle
Modeling and Defining Personalized Therapies of Neurological Disorders Using Human Pluripotent Stem Cells
Third Cycle
Liver Liquid Biopsy
Third Cycle
Metabolic Nuclear Sequestration of the Proteasome as the Achilles’ Heel of Tumor Growth: A Platform for Development of Patient-Specific Management and Treatment Modalities
Third Cycle
Prognosis, Response to Therapy, and Molecular Profiling of Cancer by Computerized Analysis of Digital Cytology and Histology Images
Third Cycle
Associating Stromal Cell Signatures with Structural Damage and Clinical Outcomes in Patients with Ulcerative Colitis
Second Cycle
Nanocode: A Barcoded Nanoparticle Based Screen for Precision Discovery of Cancer Drug Sensitivities
Second Cycle
Defining Sensitivity and Overcoming Resistance to PARP Inhibition in Pancreatic Ductal Adenocarcinoma Using Combined Genomics and Metabolomics Tools
Second Cycle
Inherited Retinal Diseases: From the Identification of Genes and Risk Factors to a New Method of Personalized Medicine
Second Cycle
Immunotherapy of Glioblastoma with Metabolically Superior Bi-Specific CAR T-Cells
Second Cycle
Dynamic Risk Prediction Model for Post-Trauma Psychopathology, Based on Multi-Scale and Multi-Layered Profiling of Stress Response
Second Cycle
Elucidating Epigenetic Mechanisms that Drive Autism Spectrum Disorder and Tailoring a Personalized Treatment
Second Cycle
Modeling Tubulopathies Using Patient-Specific Kidney Organoids for Renal Precision Medicine – Mitochondrial Disease-Associated Fanconi Syndrome as Proof of Concept
Second Cycle
Personalizing Multiple Myeloma Prognosis and Treatment: Advanced Single-Cell Genomics Analysis of the Dynamics of Tumor-Immune Crosstalk
Second Cycle
Overcoming Resistance to CAR-T Cell Therapy due to Antigen Loss or Modulation by New Chimeric Receptors Targeting Intracellular-Derived HLA Peptidome
Second Cycle
The Delivery Mechanism of Tumor-Derived Extracellular Vesicles
Second Cycle
Understanding the Relation of Cellular and Immuno-senescence in Aging and their Relevance to the Dynamics and Clinical Outcomes of Severe Infections
Second Cycle
A Computational and Experimental Personalized Medicine Approach for the Diagnosis and Treatment of Rare Genetic Diseases
Second Cycle
Personalized Risk Assessment of Colorectal Cancer Based on Natural Anti-Cancer Defense Mechanisms: A Potential Tool for Prevention and Early Detection
Second Cycle
Towards Precision Therapy in Infectious Diseases – Personalizing Bacteriophage and Antibiotic Treatments
Second Cycle
Genetic and Epigenetic Modifiers of Disease Phenotypes – Skin Diseases as a Paradigm
Second Cycle
A Personalized 3D Oxygen-Sensing Skin Graft for the Diagnosis and Treatment of Chronic Wounds in Patients with Diabetes
First Cycle
Big Data to Therapy: Personalized Medicine for the Deaf in the Diverse Jewish Population
First Cycle
Advancing Immunotherapy with Metabolic Drugs: Towards Improved Melanoma Treatment
First Cycle
The Israel Leukemia Registry: Integration of an AML Clinical Database with Personalized Ex Vivo and In Vivo Validated Single-Cell Characteristics to Improve Prognosis
First Cycle
Evaluating the Risk of Developing Type-2 Diabetes Based on DNA Methylation Signatures at Key Regulatory Elements in Peripheral Whole Blood
First Cycle
Combined Omics and Electronic Medical Records: Big Data for Prediction of Phenotype Sub-Types, Progression, and Treatment
First Cycle
Big Data Integration for Personalized Diagnosis of Infectious Diseases: Group A Streptococcal Pharyngitis and Influenza
First Cycle
A Single-Cell-Based Approach to Study Transcriptomic Heterogeneity in Prenatal Clinical Samples from Congenital Human Cytomegalovirus (HCMV) Infections
First Cycle
Development and Application of an Advanced Analysis Platform for MRI-Based Blood Vessel Characterization in Tumor/Benign Breast Tissues for Personalized Patient Management
First Cycle
Predicting Cardiovascular Disease Risk from Personalized Multi-Omic Data
First Cycle
Primary Immunodeficiencies: From Early Diagnosis and Gene Discovery to Personalized Therapy
First Cycle
Personalized Treatment of Urinary Tract Infections with Antibiotics
First Cycle
Neuronal Hyperactivity in Prodromal Alzheimer’s Disease: Combining Comprehensive Digital Health, Imaging and Biochemical/Molecular Analyses Towards Personalized Diagnosis
First Cycle
Towards Population-Wide Cancer Early Diagnosis Via Cost-Effective Metabolomics of Serum Samples
First Cycle
Multi-Dimensional Analysis and the Human Aging Blood System
Look for something?